Basic Information
RNALocate ID: RLID:01002694
RNA Symbol: hsa-miR-708-5p
Localization: Mitochondrion
RNA Information
RNA Name: hsa-miR-708
RNA ID: miRBase:MIMAT0004926
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 21637849
Tissue/Cell Line: Skeletal muscle myoblasts
Method: ISH|qRT-PCR
Description: List of microRNA significantly detected in the mitochondrial mRNA at three increasing mtRNA inputs (1, 5 and 35 uL). Table S3 List of microRNA significantly detected (Cp<35) in the mitochondrial mRNA at the two highest mtRNA inputs (5 and 35 uL). Data are collected from Table 4 and S3.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002695 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:11004120 Exosome Plasma 23663360
RLID:11004121 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000717 Microvesicle Fibroblasts|Mesenchymal stem cells
RLID-D:11001599 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-708-5p Oral squamous cell carcinoma MNDR-E-MI-68056
MNDR hsa-miR-708-5p Small intestinal neuroendocrine tumor MNDR-E-MI-68057
MNDR hsa-miR-708-5p High-grade serous ovarian carcinoma MNDR-E-MI-68058
MNDR hsa-miR-708-5p Ovarian clear cell carcinoma MNDR-E-MI-68059
MNDR hsa-miR-708-5p Lymphoma MNDR-E-MI-68060
MNDR hsa-miR-708-5p Estrogen-receptor positive breast cancer MNDR-E-MI-68061
MNDR hsa-miR-708-5p Estrogen-receptor negative breast cancer MNDR-E-MI-68062
MNDR hsa-miR-708-5p Progesterone-receptor positive breast cancer MNDR-E-MI-68063
MNDR hsa-miR-708-5p Progesterone-receptor negative breast cancer MNDR-E-MI-68064
MNDR hsa-miR-708-5p Her2-receptor positive breast cancer MNDR-E-MI-68065
MNDR hsa-miR-708-5p Breast cancer luminal MNDR-E-MI-68066
MNDR hsa-miR-708-5p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-68067
MNDR hsa-miR-708-5p B cell acute lymphoblastic leukemia MNDR-E-MI-68068
MNDR hsa-miR-708-5p Small intestine cancer MNDR-E-MI-68069
MNDR hsa-miR-708-5p Prostate cancer MNDR-E-MI-68070
MNDR hsa-miR-708-5p Chronic lymphocytic leukemia MNDR-E-MI-68071
MNDR hsa-miR-708-5p Gastric cancer MNDR-E-MI-68072
MNDR hsa-miR-708-5p Alzheimer disease MNDR-E-MI-68073
MNDR hsa-miR-708-5p Urinary bladder cancer MNDR-E-MI-68074
MNDR hsa-miR-708-5p Esophageal carcinoma MNDR-E-MI-68075
MNDR hsa-miR-708-5p Dysautonomia familial MNDR-E-MI-68076
MNDR hsa-miR-708-5p Graves disease MNDR-E-MI-68077
MNDR hsa-miR-708-5p Leukemia MNDR-E-MI-68078
MNDR hsa-miR-708-5p Huntington disease MNDR-E-MI-68079
MNDR hsa-miR-708-5p Lung cancer MNDR-E-MI-68080
MNDR hsa-miR-708-5p Parkinson disease MNDR-E-MI-68081
MNDR hsa-miR-708-5p Primary pulmonary hypertension MNDR-E-MI-68082
MNDR hsa-miR-708-5p Basal-like breast cancer MNDR-E-MI-68083
MNDR hsa-miR-708-5p Cancer MNDR-E-MI-68084
MNDR hsa-miR-708-5p Thyroid cancer MNDR-E-MI-68085
MNDR hsa-miR-708-5p Pancreatic cancer MNDR-E-MI-68086
MNDR hsa-miR-708-5p Rectum adenocarcinoma MNDR-E-MI-68087
MNDR hsa-miR-708-5p Nephroblastoma MNDR-E-MI-68088
MNDR hsa-miR-708-5p Colon cancer MNDR-E-MI-68089
MNDR hsa-miR-708-5p Colon adenocarcinoma MNDR-E-MI-68090
MNDR hsa-miR-708-5p Relapsing-remitting multiple sclerosis MNDR-E-MI-68091
MNDR hsa-miR-708-5p Prostate adenocarcinoma MNDR-E-MI-68092
MNDR hsa-miR-708-5p Laryngeal neoplasms MNDR-E-MI-68093
MNDR hsa-miR-708-5p Endometriosis MNDR-E-MI-68094
MNDR hsa-miR-708-5p Carcinoma ductal breast MNDR-E-MI-68095
MNDR hsa-miR-708-5p Glioblastoma MNDR-E-MI-68096
MNDR hsa-miR-708-5p Amyotrophic lateral sclerosis MNDR-E-MI-68097
MNDR hsa-miR-708-5p Ewing sarcoma MNDR-E-MI-68098
MNDR hsa-miR-708-5p Gastric adenocarcinoma MNDR-E-MI-68099
MNDR hsa-miR-708-5p Lung squamous cell carcinoma MNDR-E-MI-68100
MNDR hsa-miR-708-5p Carcinoma lung non-small-cell MNDR-E-MI-68101
MNDR hsa-miR-708-5p Lung adenocarcinoma MNDR-E-MI-68102
MNDR hsa-miR-708-5p Thyroid carcinoma MNDR-E-MI-68103
MNDR hsa-miR-708-5p Ovarian carcinoma MNDR-E-MI-68104
MNDR hsa-miR-708-5p Bladder urothelial carcinoma MNDR-E-MI-68105
MNDR hsa-miR-708-5p Pancreatic adenocarcinoma MNDR-E-MI-68106
MNDR hsa-miR-708-5p Carcinoma renal cell MNDR-E-MI-68107
MNDR hsa-miR-708-5p Kidney renal papillary cell carcinoma MNDR-E-MI-68108
MNDR hsa-miR-708-5p Renal clear cell carcinoma MNDR-E-MI-68109
MNDR hsa-miR-708-5p Biliary tract cancer MNDR-E-MI-68110
MNDR hsa-miR-708-5p Cholangiocarcinoma MNDR-E-MI-68111
MNDR hsa-miR-708-5p Esophageal cancer MNDR-E-MI-68112
MNDR hsa-miR-708-5p Synovial sarcoma MNDR-E-MI-68113
MNDR hsa-miR-708-5p Head and neck squamous cell carcinoma MNDR-E-MI-68114
MNDR hsa-miR-708-5p Breast invasive carcinoma MNDR-E-MI-68115
MNDR hsa-miR-708-5p Hepatocellular carcinoma MNDR-E-MI-68116
MNDR hsa-miR-708-5p Hodgkin lymphoma MNDR-E-MI-68117
MNDR hsa-miR-708-5p Colorectal cancer MNDR-E-MI-68118
MNDR hsa-miR-708-5p Nasopharynx carcinoma MNDR-E-MI-68119
MNDR hsa-miR-708-5p Multiple myeloma MNDR-E-MI-68120
MNDR hsa-miR-708-5p Nasopharyngeal cancer MNDR-E-MI-68121
MNDR hsa-miR-708-5p Prostatic neoplasms MNDR-E-MI-68122
MNDR hsa-miR-708-5p Aids dementia complex MNDR-E-MI-68123
MNDR hsa-miR-708-5p Subarachnoid hemorrhage traumatic MNDR-E-MI-68124
MNDR hsa-miR-708-5p Breast cancer her3+ negative MNDR-E-MI-68125
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter AKT1 Homo sapiens RR00067020
TOP